Glimepiride is an oral antidiabetic agent belonging to the sulfonylurea class, primarily used in the management of type 2 diabetes mellitus. It helps control blood sugar levels by stimulating the release of insulin from pancreatic beta cells. This high-purity compound (≥98% HPLC) is suitable for pharmaceutical research, development, and as an active pharmaceutical ingredient (API). It is typically used in combination with other agents like metformin for better glycemic control. Regular monitoring for hypoglycemia is advised in clinical use.